Home / India News / And now, a seaweed-based nutraceutical cure for fatty liver disease

And now, a seaweed-based nutraceutical cure for fatty liver disease

Pre-clinical trials show no evidence of side effects in the product, which is the ninth such to be developed from marine organisms by Kochi-based CMFRI

Premium

Photo: Shutterstock

1 min read Last Updated : Sep 27 2022 | 7:22 PM IST

The Central Marine Fisheries Research Institute (CMFRI) based in Kochi has come up with a nutraceutical product from select seaweeds to treatment of non-alcoholic fatty liver disease (NAFLD). Named Cadalmin LivCure extract, the product is a unique blend of 100 per cent natural bioactive ingredients extracted from seaweeds to improve liver health.

This is the ninth such product from marine organisms being developed by the CMFRI, which works under the Indian Council of Agriculture Research (ICAR). The umbrella organisation had already brought out nutraceuticals to combat a series of lifestyle diseases such as type-2 diabetes, arthritis, cholesterol, hypertension, hypothyroidism and

What you get on BS Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.

VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in